. 2017 May 8;36(35):5045–5057. doi: 10.1038/onc.2017.118

Table 1. The relationships between CYP4A⁺ TAM counts and clinicopathological features in samples from 140 patients with breast cancer.

Clinicopathological features	Cases	CYP4A⁺ TAM counts		χ²	P
		Low	High
Age (years)
⩽54	71	35	36	0.029	0.866
>54	69	35	34

T stage
T1	57	36	21	6.658	0.010*
T2+T3	83	34	49

Lymph node metastasis
0	75	45	30	6.462	0.011*
⩾1	65	25	40

Pathological grade
I–II	98	55	43	4.898	0.027*
III	42	15	27

TNM stage
I	33	25	8	11.459	0.001*
II–III	107	45	62

ER status
Negative	41	26	15	4.702	0.030*
Positive	95	41	54

PR status
Negative	64	41	23	11.043	0.001*
Positive	73	26	47

Her-2 status
Negative	61	34	27	3.784	0.052
Positive	58	22	36

Abbreviations: ER, estrogen receptor; Her-2, human epidermal growth factor receptor-2; PR, progesterone receptor; TNM, tumor node metastasis.

*P<0.05.

Table 1. The relationships between CYP4A+ TAM counts and clinicopathological features in samples from 140 patients with breast cancer.